Assyro AI

Orange Book product · Brand (NDA)

INOMAX

NITRIC OXIDE

Brand (NDA)NDA 020845RX MALLINCKRODT IRELAND

At a glance

Jan 17, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 17, 2023

    3 yr 6 mo ago

  2. Today

  3. Patent 11931377 expires

    Listed drug substance patent expiration.

    Jun 30, 2029

    in 3 yr 1 mo

Pharmaceutical detail

Active ingredient

NITRIC OXIDE

Strength

4880PPM

Dosage form

GAS

Route

INHALATION

TE code

Not listed

Application

NDA 020845

Product number

004

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11931377Jun 30, 2029in 3 yr 1 mo
SubstanceProductU-3903
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.